Background illustration for clinical trials search

Paid Clinical Trials Bethesda

Discover 2,414 paid clinical trials in Bethesda, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to See if Tolvaptan Can Delay Dialysis in Infants and Children Who at Enrollment Are 28 Days to Less Than 12 Weeks Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)

for
Autosomal Recessive Polycystic Kidney Disease (ARPKD)
Location: Washington D.C. DC, Baltimore MD, Cleveland OH,
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.

Sex: All

Age: 0

Code: NCT04786574

Phase3, Recruiting

Oral Deucrictibant for Prophylactic and Acute Treatment in Hereditary Angioedema Patients

for
Hereditary Angioedema (HAE), Angioedema,
Location: Wheaton MD
Sponsor: Institute for Asthma and Allergy

Sex: All

Age: 18 - 70+

Code: NCT07046806

Phase1, Phase2, Recruiting

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

for
Stage I Mixed Cell Type Kidney Wilms Tumor,
Location: Washington D.C. DC, Falls Church VA, Baltimore MD,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 30

Code: NCT06401330

Phase3, Recruiting

A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia

for
Leukemia, Juvenile Myelomonocytic, JMML, JCML,
Location: Washington D.C. DC, Baltimore MD, Philadelphia PA,
Sponsor: Therapeutic Advances in Childhood Leukemia Consortium

Sex: All

Age: 0 - 21

Code: NCT05849662

Phase1, Phase2, Recruiting

A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

for
Chronic Graft-versus-host-disease
Location: Washington D.C. DC, Baltimore MD, Richmond VA,
Sponsor: Incyte Corporation

Sex: All

Age: 12+

Code: NCT06585774

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Digoxin Medulloblastoma Study

for
Medulloblastoma, Medulloblastoma, Non-WNT/Non-SHH
Location: Washington D.C. DC, Baltimore MD, The Bronx NY,
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 1 - 30

Code: NCT06701812

Phase2, Recruiting

National Collaborative to Improve Care of Children With Complex Congenital Heart Disease

for
Hypoplastic Left Heart Syndrome (HLHS)
Location: Washington D.C. DC, Falls Church VA, Baltimore MD,
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 0 - 1

Code: NCT02852031

Recruiting

T Cell Therapy Opposing Novel COVID-19 Infection in Immunocompromised Patients

for
SARS-CoV-2 Infection
Location: Washington D.C. DC, Baltimore MD
Sponsor: Children's National Research Institute

Sex: All

Age: 2 - 70+

Code: NCT05141058

Phase1, Recruiting

A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)

for
Autosomal Recessive Polycystic Kidney (ARPKD)
Location: Washington D.C. DC, Baltimore MD, Cleveland OH,
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.

Sex: All

Age: 0 - 18

Code: NCT04782258

Phase3, Recruiting

A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma

for
Basal Ganglia Germinoma, Diabetes Insipidus, Germinoma,
Location: Washington D.C. DC, Baltimore MD, Wilmington DE,
Sponsor: Children's Oncology Group

Sex: All

Age: 3 - 29

Code: NCT06368817

Phase2, Recruiting

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

for
Obesity, Overweight, Chronic Weight Management
Location: Silver Spring MD, Columbus OH, Wilmington NC,
Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07654361

Phase3, Recruiting

Inappropriate Sinus Tachycardia Registry

for
Inappropriate Sinus Tachycardia, Postural Tachycardia Syndrome
Location: Hyattsville MD, Cincinnati OH, Gainesville FL,
Sponsor: AtriCure, Inc.

Sex: All

Age: 18 - 70+

Code: NCT05107635

Recruiting

A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)

for
Crohn's Disease, Ulcerative Colitis
Location: Glen Burnie MD, Tyler TX
Sponsor: Takeda

Sex: All

Age: 18 - 70+

Code: NCT06764615

Phase2, Recruiting

Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Acute Femoropopliteal DVT

for
Thrombosis, Deep Vein, Iliofemoral; Thrombosis
Location: Hyattsville MD, Norfolk VA, Pittsburgh PA, Englewood NJ,
Sponsor: Mercator MedSystems, Inc.

Sex: All

Age: 18 - 70+

Code: NCT04862468

Phase2, Recruiting

Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer

for
Low-grade NMIBC, FGFR Gene Amplification, FGFR Gene Alterations,
Location: Baltimore MD, Lancaster PA, Bala-Cynwyd PA,
Sponsor: Tyra Biosciences, Inc

Sex: All

Age: 18+

Code: NCT06995677

Phase2, Recruiting

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

for
Alzheimer Disease
Location: Gaithersburg MD, Princeton NJ, Woodmere NY,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 55 - 70+

Code: NCT07011732

Phase3, Recruiting

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

for
Graves' Disease
Location: Washington D.C. DC, Baltimore MD, Newark DE,
Sponsor: Immunovant Sciences GmbH

Sex: All

Age: 18 - 70+

Code: NCT06727604

Phase2, Recruiting

Prospective Study to Assess a Diagnostic Aid for Cancer

for
Cancer
Location: Annapolis MD, York PA, Harrisburg PA, Wyomissing PA,
Sponsor: Harbinger Health

Sex: All

Age: 45+

Code: NCT07046260

Recruiting

Optimizing Dimensions of Reinforcement

for
Intellectual Disabilities (F70-F79), Autism
Location: Baltimore MD, Rochester Hills MI, Auburn AL
Sponsor: Auburn University

Sex: All

Age: 6 - 17

Code: NCT07137273

Recruiting

Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

for
Relapsing Multiple Sclerosis
Location: Washington D.C. DC, Olney MD, Richmond VA, Teaneck NJ,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 40 - 70

Code: NCT06846281

Phase3, Recruiting